EUROLYSE IVS: Financial statements 2020
CVR: 36462191
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
EUROLYSE IVS (CVR 36462191) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2020 report amounted to DKK 100. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK 100
- Total Assets
- DKK 100
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 0 | 0 | 0 | 100 | - |
| 2019 | - | 0 | 0 | 100 | - |
| 2018 | - | 0 | 0 | 100 | - |
| 2017 | - | 0 | 0 | 100 | - |
| 2016 | - | 0 | 0 | 100 | - |
Official annual report
How creditworthy is EUROLYSE IVS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
EUROLYSE IVS has published its annual report for 2019. Gross profit came to DKK 0, and the net result was DKK 0.
About EUROLYSE IVS
EUROLYSE IVS was a Danish company of the type Iværksætterselskab based in Frederikssund, founded in 2014. The company has been dissolved on 22 January 2025. The company was registered under the industry Ikke-finansielle holdingselskaber. The company was previously named CRETECSYS IVS. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2024 report amounted to DKK 100.